Literature DB >> 3732218

Lung changes in rats following inhalation exposure to volcanic ash for two years.

A P Wehner, G E Dagle, M L Clark, R L Buschbom.   

Abstract

Rats were exposed by inhalation to 5 or 50 mg/m3 Mount St. Helens volcanic ash, to 50 mg/m3 quartz (positive controls), or to filtered room air (sham-exposed controls), for 6 hr/day, 5 days/week, for up to 24 months to investigate biological effects of chronic inhalation exposure to volcanic ash under controlled laboratory conditions. Exposure-related lung changes comprised accelerated respiratory frequency; alveolar macrophage accumulation; interstitial reaction; lymphoreticular reaction in peribronchiolar regions and in mediastinal lymph nodes; alveolar proteinosis in the 50- mg/m3 ash- or quartz-exposed groups; increase in fresh lung weights; decreased body weight and increased mortality in the quartz-exposed group; and epidermoid carcinomas especially in the quartz-exposed females and, to a lesser extent, in the 50-mg/m3 ash-exposed females. The observed changes reflect significant dose-response and agent-response relationships.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732218     DOI: 10.1016/s0013-9351(86)80125-6

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  3 in total

Review 1.  The role of surfactant in the pulmonary reaction to mineral particles.

Authors:  A G Heppleston
Journal:  Int J Exp Pathol       Date:  1991-10       Impact factor: 1.925

2.  The structure of volcanic cristobalite in relation to its toxicity; relevance for the variable crystalline silica hazard.

Authors:  Claire J Horwell; Benedict J Williamson; Ken Donaldson; Jennifer S Le Blond; David E Damby; Leon Bowen
Journal:  Part Fibre Toxicol       Date:  2012-11-19       Impact factor: 9.400

Review 3.  Relevance of particle-induced rat lung tumors for assessing lung carcinogenic hazard and human lung cancer risk.

Authors:  J L Mauderly
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.